Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial
Articles > Article · 2019
Authors: BİRSEN PINAR YILDIZ, MESUT BAYRAKTAROĞLU, DİDEM GÖRGÜN, Kıvanç YÜKSEL
CLINICAL DRUG INVESTIGATION, Journal Indexed in SCI Expanded, International, 2019